Current and future treatment strategies in chronic lymphocytic leukemia

Treatment decisions for patients with chronic lymphocytic leukemia (CLL) are dependent on symptoms and classification into high-, medium-, or low-risk categories. The prognosis for CLL hinges, in part, on the presence or absence of less-favorable genetic aberrations, including del(17p), del(11q), TP...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Krish, Pagel, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074228/
https://www.ncbi.nlm.nih.gov/pubmed/33902665
http://dx.doi.org/10.1186/s13045-021-01054-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074228/
https://www.ncbi.nlm.nih.gov/pubmed/33902665
http://dx.doi.org/10.1186/s13045-021-01054-w

Ejemplares similares